Adaptimmune Therapeutics - 48 Year Dividend History | ADAP

Historical dividend payout and yield for Adaptimmune Therapeutics (ADAP) since 1971. The current TTM dividend payout for Adaptimmune Therapeutics (ADAP) as of November 15, 2019 is $0.00. The current dividend yield for Adaptimmune Therapeutics as of November 15, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.084B $0.060B
Adaptimmune Therapeutics plc is a biopharmaceutical company. The Company is focused on cancer immunotherapy products based on T-cell receptor platform. Adaptimmune Therapeutics plc is based in Abingdon, United Kingdom.
Stock Name Country Market Cap PE Ratio